[Press Release] 2018 Public Opinion Survey on Japanese Healthcare Policies (Preliminary report)
date : 8/28/2018
About 60% of respondents avoid food & drink establishments that allow smoking
About 40% of respondents worry about the effects of e-cigarettes on health
HGPI (Chairman: Kiyoshi Kurokawa) has been undertaking regular surveys of public opinion on healthcare issues since 2006 in order to gain a better understanding of public perceptions and a better awareness of the health services and healthcare policies that the public desires.
This year, in 2018, an internet-based public opinion survey was administered to 1,000 males and females aged 20 and over throughout Japan. The survey was comprised of questions on passive smoking, the HPV vaccine, and end-of-life care. The survey’s preliminary report is set to be released on August 28.
Survey Highlights
. 58.1% avoid food & drink establishments that allow smoking
. 35.8% worry about the health effects of e-cigarette secondhand smoke
. 67.0% are unsure whether the HPV vaccine should be recommended
. 66.4% want to discuss end-of-life care, and 25.4% already have
(includes discussion of end-of-life care for either themselves or someone else)
* For further details on the survey, please download the preliminary report (in Japanese).
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



